TY  - GEN
AU  - Gómez-Casares,M T
AU  - García-Alegria,E
AU  - López-Jorge,C E
AU  - Ferrándiz,N
AU  - Blanco,R
AU  - Alvarez,S
AU  - Vaqué,J P
AU  - Bretones,G
AU  - Caraballo,J M
AU  - Sánchez-Bailón,P
AU  - Delgado,M D
AU  - Martín-Perez,J
AU  - Cigudosa,J C
AU  - León,J
TI  - MYC antagonizes the differentiation induced by imatinib in chronic myeloid leukemia cells through downregulation of p27(KIP1.)
SN  - 1476-5594
PY  - 2013///0619
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Benzamides
KW  - Cell Differentiation
KW  - Cell Line, Tumor
KW  - Cell Proliferation
KW  - Cyclin-Dependent Kinase Inhibitor p27
KW  - genetics
KW  - Dasatinib
KW  - Down-Regulation
KW  - Erythroid Cells
KW  - drug effects
KW  - Gene Expression
KW  - Gene Expression Regulation, Leukemic
KW  - Humans
KW  - Imatinib Mesylate
KW  - Leukemia, Myelogenous, Chronic, BCR-ABL Positive
KW  - Piperazines
KW  - Proto-Oncogene Proteins c-myc
KW  - physiology
KW  - Pyrimidines
KW  - S-Phase Kinase-Associated Proteins
KW  - metabolism
KW  - Thiazoles
KW  - beta-Globins
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/onc.2012.246
ER  -